Followers | 657 |
Posts | 83618 |
Boards Moderated | 0 |
Alias Born | 05/25/2008 |
Saturday, June 24, 2023 12:00:52 AM
Recent HOOK News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:04:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:03:13 AM
- HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/09/2024 11:01:00 AM
- HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab • GlobeNewswire Inc. • 04/25/2024 11:01:00 AM
- HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers • GlobeNewswire Inc. • 04/24/2024 11:01:00 AM
- HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration • GlobeNewswire Inc. • 04/10/2024 11:01:00 AM
- HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 03/22/2024 11:01:00 AM
- HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/06/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:30:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:12:08 PM
- HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs • GlobeNewswire Inc. • 01/29/2024 01:01:00 PM
- HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization • GlobeNewswire Inc. • 01/16/2024 12:01:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/05/2024 05:15:14 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 12:33:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 12:06:13 PM
- HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences • GlobeNewswire Inc. • 12/21/2023 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:46:37 PM
- HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus • GlobeNewswire Inc. • 11/20/2023 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:10:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:05:09 PM
- HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 11/09/2023 12:01:00 PM
- HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023 • GlobeNewswire Inc. • 11/03/2023 04:01:00 PM
- HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023 • GlobeNewswire Inc. • 11/02/2023 08:01:00 PM
- HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023 • GlobeNewswire Inc. • 10/22/2023 10:01:00 AM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM